Assoc Director for Innovation and Partnerships, OCP, OTS, CDER, FDA, United States
Dr. Qi Liu is a Senior Science Advisor in the Office of Clinical Pharmacology (OCP), FDA. At FDA, Qi contributed to the review of over 200 NDA/sNDA, 20 BLA/sBLA, and numerous IND. Qi co-authored about 40 manuscripts and presented on many topics at Advisory Committee meetings and scientific...
Read More →